The store will not work correctly when cookies are disabled.
8-(2-(1H-Indol-3-yl)ethyl)-1,3-dimethyl-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione
ID: ALA4780863
PubChem CID: 162663623
Max Phase: Preclinical
Molecular Formula: C19H20N6O2
Molecular Weight: 364.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(=O)c2c(nc3n2CCN3CCc2c[nH]c3ccccc23)n(C)c1=O
Standard InChI: InChI=1S/C19H20N6O2/c1-22-16-15(17(26)23(2)19(22)27)25-10-9-24(18(25)21-16)8-7-12-11-20-14-6-4-3-5-13(12)14/h3-6,11,20H,7-10H2,1-2H3
Standard InChI Key: ATZZJVXUQAQOAR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
16.6492 -8.9189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6492 -9.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3545 -10.1406 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3545 -8.5062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0598 -8.9189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0643 -9.7326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8395 -9.9798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3545 -7.6890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9421 -10.1458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3549 -10.9578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9403 -8.5124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8345 -8.6655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3099 -9.3141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0737 -9.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0703 -8.2582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3045 -8.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7368 -9.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4820 -9.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1451 -9.6821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1526 -10.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9309 -10.7458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9253 -9.4236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4064 -10.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2153 -9.9940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5441 -9.2479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0580 -8.5892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2508 -8.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 13 2 0
12 5 1 0
4 8 2 0
2 9 2 0
3 10 1 0
1 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
14 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 23 1 0
22 19 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.41 | Molecular Weight (Monoisotopic): 364.1648 | AlogP: 0.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 80.85 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.19 | CX LogD: 2.19 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.59 | Np Likeness Score: -1.25 |
References
1. Schoeder CT,Mahardhika AB,Drabczyńska A,Kieć-Kononowicz K,Müller CE. (2020) Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18., 11 (10): [PMID:33062188] [10.1021/acsmedchemlett.0c00208] |